Curatively intended radiotherapy for prostate cancer : Detection of disseminated tumor cells and long-term outcomes
Appears in the following Collection
AbstractList of original papers
Paper I Berg A, Lilleby W, Bruland ØS, Fosså SD. 10-year survival and quality of life in patients with high-risk pN0 prostate cancer following definitive radiotherapy. International Journal of Radiation Oncology*Biology*Physics 2007;69:1074-1083.
Paper II Berg A, Dahl AA, Bruland ØS, Bjøro T, Aanensen MS, Fosså SD. Definitive radiotherapy with adjuvant long-term antiandrogen treatment for locally advanced prostate cancer. Health- related quality of life and hormonal changes. Accepted for publication in Prostate Cancer and Prostatic Diseases.
Paper III Berg A, Berner A, Lilleby W, Bruland ØS, Fosså SD, Nesland JM, Kvalheim G. Impact of disseminated tumor cells in bone marrow at diagnosis in patients with nonmetastatic prostate cancer treated by definitive radiotherapy. Int J Cancer 2007; 120:1603-1609
Paper IV Berg A, Bruland ØS, Fosså SD, Nesland JM, Berner A, Schirmer C, Lilleby W. Disseminated tumor cells in bone marrow following definitive radiotherapy for intermediate or high-risk prostate cancer. Prostate 2008; 68:1607-1614